Business Context and Reporting Period
Company: United Security Bancshares, Inc. (Note: Metadata listed "First US Bancshares," but filing text confirms "United Security Bancshares, Inc.")
Filing Type: Form 10-Q (Unaudited)
Period Ended: March 31, 2003
Business Overview: The registrant is a bank holding company with no operations of consequence other than ownership of its subsidiaries, primarily First United Security Bank and Acceptance Loan Company, Inc.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 | Dec 31, 2002 |
|---|---|---|---|
| Total Assets | $546.2 million | $534.6 million | $535.3 million |
| Total Deposits | $364.9 million | $365.8 million | $353.1 million |
| Net Loans (Net of Allowance) | $349.1 million | $338.2 million | $351.4 million |
| Net Interest Income | $8.06 million | $7.61 million | N/A |
| Net Income | $2.34 million | $2.13 million | N/A |
| Diluted EPS | $0.73 | $0.64 | N/A |
| Return on Assets (Annualized) | 1.75% | 1.63% | N/A |
| Return on Equity (Annualized) | 14.0% | 13.3% | N/A |
| Allowance for Loan Losses | $6.92 million | $6.34 million | $6.62 million |
| Non-Performing Assets | $9.19 million | $6.05 million | $8.96 million |
| Cash Flow from Operations | $2.08 million | $2.39 million | N/A |
Material Changes vs. Prior Period
- Profitability: Net income increased 9.9% ($210,000) compared to Q1 2002, driven by a 5.9% increase in net interest income and a 28.6% increase in non-interest income (excluding securities gains).
- Interest Rates: Interest expense decreased 16.2% due to lower rates paid on deposits and borrowings. Interest income decreased 1.2% due to lower yields on investments, despite higher loan volumes.
- Asset Growth: Total assets increased $10.9 million from year-end 2002, primarily due to a $13.7 million increase in investment securities funded by a $11.8 million increase in deposits.
- Loan Portfolio: Net loans decreased $2.0 million from year-end 2002. Net charge-offs decreased 35% to $699,000, reflecting improvements in the finance company subsidiary's portfolio.
- Credit Quality: Non-performing assets increased to $9.19 million (2.56% of net loans) from $6.05 million in Q1 2002, largely due to a $1.6 million increase in real estate acquired in settlement of loans.
Outlook, Risks, and Management Commentary
- Management Commentary: Management attributes the increase in net interest income to a 12 basis point improvement in net yield on earning assets. Non-interest expense rose 4.6% due to merit increases and higher benefit costs.
- Capital and Liquidity: The company remains in compliance with all regulatory capital requirements. Liquidity sources include $130 million in borrowing capacity from the Federal Home Loan Bank and $30 million in Federal Funds lines.
- Accounting Changes: The company adopted FASB Statement No. 145 (debt extinguishment) and Interpretation No. 45 (guarantees) with no material impact. The company is currently assessing the impact of Interpretation No. 46 regarding variable interest entities (limited partnership investments in affordable housing).
- Risks: The company is a defendant in legal actions arising in the ordinary course of business; management does not expect a material adverse effect. Credit risk remains a factor, with management noting that the allowance for loan losses is subject to adjustment based on economic conditions and collateral values.
Investor Verification Checklist
- Credit Quality Trend: Verify the sustainability of the decrease in net charge-offs given the increase in non-performing assets and real estate acquired in settlement.
- Yield Compression: Monitor the trend of interest income yields, which decreased in Q1 2003 despite higher loan volumes.
- Variable Interest Entities: Review future filings for the final determination on consolidation of affordable housing partnerships under FASB Interpretation No. 46.
- Expense Management: Track non-interest expense growth relative to revenue, as salaries and benefits increased significantly.
- Legal Contingencies: Monitor updates on ongoing legal proceedings to ensure no material adverse effects materialize.